According to Davis Marcus Partners, a joint venture between Marcus Partners and The Davis Companies, in partnership with Prudential Real Estate Investors (PREI), Alkermes, Inc. signed a 100,000 s/f lease in the expansive Reservoir Woods campus.
Alkermes, a fully integrated biotechnology company, will relocate its headquarters from Cambridge to 850-852 Winter St., a new 180,000 s/f LEED Gold certified office and lab building. The company anticipates that the move will be completed in early 2010.
"We are delighted to join a growing cluster of biotechnology companies in Waltham. The new building provides us with a central location and an opportunity to design a state-of-the-art space that specifically fits our needs," said Gordon Pugh, chief operating officer of Alkermes. "It has been a pleasure to work with an owner who is as committed to providing a first class environment for our employees as we are."
"We are pleased to welcome Alkermes to the Reservoir Woods community," said Paul Marcus, CEO of Davis Marcus Partners. "Our commitment to developing best-in-class properties has enabled us to land a quality tenant in a challenging market that understands the benefits of our LEED-Gold design to both their employees and their bottom line."
All buildings at Reservoir Woods offer a comprehensive high-end amenity package that includes a full-service café and outdoor patio, fitness and wellness programs, access to the premier Health Point fitness/wellness facility located on site, plus ample parking. Together, Reservoir Woods East and West provide a campus environment with 120-acres of wooded landscape between the Mass. Tpke. and Rte. 2 at exit 27 off Rt. 128/I-95.
Reservoir Woods East and West are home to corporate tenants PerkinElmer, Battery Ventures, Fresenius Medical Care and
National Grid in addition to the premier Health Point fitness facility.
Reservoir Woods is owned by a joint venture between affiliates of Davis Marcus Partners and Prudential Real Estate Investors.
CB Richard Ellis represented the ownership in the transaction and Joseph Flaherty of Colliers Meredith & Grew represented Alkermes.